Literature DB >> 15545023

Cannabinoids and gene expression during brain development.

Javier Fernández-Ruiz1, María Gómez, Mariluz Hernández, Rosario de Miguel, José A Ramos.   

Abstract

Cannabis is the most commonly used illicit drug in western societies, in particular among young people. It is consumed even by women during pregnancy and lactation, which result in a variety of disturbances in the development of their offspring, because, like other habit-forming drugs, cannabinoids, the psychoactive ingredients of marijuana, can cross the placental barrier and be secreted in the maternal milk. Through this way, cannabinoids affect the ontogeny of various neurotransmitter systems leading to changes in different behavioral patterns. Dopamine and endogenous opioids are among the neurotransmitters that result more affected by perinatal cannabinoid exposure, which, when animals mature, produce changes in motor activity, drug-seeking behavior, nociception and other processes. These disturbances are likely originated by the capability of cannabinoids to influence the expression of key genes for both neurotransmitters, in particular, the enzyme tyrosine hydroxylase and the opioid precursor proenkephalin. In addition, cannabinoids seem to be also able to influence the expression of genes encoding for neuron-glia cell adhesion molecules, which supports a potential influence of cannabinoids on the processes of cell proliferation, neuronal migration or axonal elongation in which these proteins are involved. In support of this possibility, CB1 receptors, which represent the major targets for the action of cannabinoids, are abundantly expressed in certain brain regions, such as the subventricular areas, which have been involved in these processes during brain development. Finally, cannabinoids might also be involved in the apoptotic death that occurs during brain development, possibly by influencing the expression of Bcl-2/Bax system. Also in support of this option, CB1 receptors are transiently expressed during brain development in different group of neurons which do not contain these receptors in the adult brain. This paper will review all evidence relating cannabinoids to the expression of key genes for neural development, trying to establish the future research addressed to elucidate the mechanisms involved in the epigenetic action of cannabinoids during brain development.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15545023     DOI: 10.1007/bf03033314

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  93 in total

Review 1.  Control of the cell survival/death decision by cannabinoids.

Authors:  M Guzmán; C Sánchez; I Galve-Roperh
Journal:  J Mol Med (Berl)       Date:  2001       Impact factor: 4.599

2.  Preferential limbic expression of the cannabinoid receptor mRNA in the human fetal brain.

Authors:  X Wang; D Dow-Edwards; E Keller; Y L Hurd
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

3.  Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry.

Authors:  P Mailleux; J J Vanderhaeghen
Journal:  Neuroscience       Date:  1992       Impact factor: 3.590

Review 4.  Trophic effects of neurotransmitters during brain maturation.

Authors:  M B Emerit; M Riad; M Hamon
Journal:  Biol Neonate       Date:  1992

5.  Expression of the CB1 and CB2 receptor messenger RNAs during embryonic development in the rat.

Authors:  N E Buckley; S Hansson; G Harta; E Mezey
Journal:  Neuroscience       Date:  1998-02       Impact factor: 3.590

6.  Effects of perinatal exposure to delta 9-tetrahydrocannabinol on the fetal and early postnatal development of tyrosine hydroxylase-containing neurons in rat brain.

Authors:  A Bonnin; R de Miguel; J G Castro; J A Ramos; J J Fernandez-Ruiz
Journal:  J Mol Neurosci       Date:  1996       Impact factor: 3.444

Review 7.  Mutations in the cell adhesion molecule L1 cause mental retardation.

Authors:  E V Wong; S Kenwrick; P Willems; V Lemmon
Journal:  Trends Neurosci       Date:  1995-04       Impact factor: 13.837

8.  Anandamide and WIN 55212-2 inhibit cyclic AMP formation through G-protein-coupled receptors distinct from CB1 cannabinoid receptors in cultured astrocytes.

Authors:  S Sagan; L Venance; Y Torrens; J Cordier; J Glowinski; C Giaume
Journal:  Eur J Neurosci       Date:  1999-02       Impact factor: 3.386

9.  Changes in prodynorphin and POMC gene expression in several brain regions of rat fetuses prenatally exposed to Delta(9)-tetrahydrocannabinol.

Authors:  Alberto Pérez-Rosado; María Gómez; Jorge Manzanares; José A Ramos; Javier Fernández-Ruiz
Journal:  Neurotox Res       Date:  2002-05       Impact factor: 3.911

10.  Astrocyte-derived TGF-beta 2 and NGF differentially regulate neural recognition molecule expression by cultured astrocytes.

Authors:  B Saad; D B Constam; R Ortmann; M Moos; A Fontana; M Schachner
Journal:  J Cell Biol       Date:  1991-10       Impact factor: 10.539

View more
  31 in total

Review 1.  Gene-environment interplay in alcoholism and other substance abuse disorders: expressions of heritability and factors influencing vulnerability.

Authors:  Tomas Palomo; R M Kostrzewa; R J Beninger; T Archer
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

2.  Cannabinoid receptors CB1 and CB2 form functional heteromers in brain.

Authors:  Lucía Callén; Estefanía Moreno; Pedro Barroso-Chinea; David Moreno-Delgado; Antoni Cortés; Josefa Mallol; Vicent Casadó; José Luis Lanciego; Rafael Franco; Carmen Lluis; Enric I Canela; Peter J McCormick
Journal:  J Biol Chem       Date:  2012-04-24       Impact factor: 5.157

3.  Endocannabinoids potently protect the newborn brain against AMPA-kainate receptor-mediated excitotoxic damage.

Authors:  Basma Shouman; Romain H Fontaine; Olivier Baud; Leslie Schwendimann; Matthias Keller; Michael Spedding; Vincent Lelièvre; Pierre Gressens
Journal:  Br J Pharmacol       Date:  2006-05-08       Impact factor: 8.739

Review 4.  Neurotoxins and neurotoxicity mechanisms. An overview.

Authors:  Juan Segura-Aguilar; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2006-12       Impact factor: 3.911

5.  Inhibition of fatty acid amide hydrolase by chlorpyrifos in juvenile rats results in altered exploratory and social behavior as adolescents.

Authors:  Russell L Carr; Navatha Alugubelly; Kathryne de Leon; Louise Loyant; Afzaal N Mohammed; M Elizabeth Patterson; Matthew K Ross; Nicole E Rowbotham
Journal:  Neurotoxicology       Date:  2020-01-10       Impact factor: 4.294

6.  Effects of perinatal exposure to delta-9-tetrahydrocannabinol on the emotional reactivity of the offspring: a longitudinal behavioral study in Wistar rats.

Authors:  Viviana Trezza; Patrizia Campolongo; Tommaso Cassano; Teresa Macheda; Pasqua Dipasquale; Maria Rosaria Carratù; Silvana Gaetani; Vincenzo Cuomo
Journal:  Psychopharmacology (Berl)       Date:  2008-05-02       Impact factor: 4.530

7.  Cannabis and breastfeeding.

Authors:  Aurélia Garry; Virginie Rigourd; Ammar Amirouche; Valérie Fauroux; Sylvie Aubry; Raphaël Serreau
Journal:  J Toxicol       Date:  2009-04-29

Review 8.  Marijuana, Spice 'herbal high', and early neural development: implications for rescheduling and legalization.

Authors:  Delphine Psychoyos; K Yaragudri Vinod
Journal:  Drug Test Anal       Date:  2012-08-13       Impact factor: 3.345

Review 9.  Epigenetic mediation of environmental influences in major psychotic disorders.

Authors:  Bart P F Rutten; Jonathan Mill
Journal:  Schizophr Bull       Date:  2009-09-25       Impact factor: 9.306

10.  Type 1 cannabinoid receptor ligands display functional selectivity in a cell culture model of striatal medium spiny projection neurons.

Authors:  Robert B Laprairie; Amina M Bagher; Melanie E M Kelly; Denis J Dupré; Eileen M Denovan-Wright
Journal:  J Biol Chem       Date:  2014-07-18       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.